Business ❯ Corporate Governance ❯ Shareholder Rights

Litigation

Securities Class Actions Class Action Lawsuits Legal Representation Investor Advocacy Securities Fraud Investor Compensation Legal Counsel Investor Relations Class Action Robbins LLP

Richtech Robotics Investor Suits Seek Lead Plaintiff Ahead of April 3 Deadline

The complaints say the company misrepresented having a commercial collaboration with Microsoft.

Trip.com Investors Urged to Act as More Firms Press Securities Claims Over Antitrust Probe

Beyond Meat Investors Face March 24 Deadline in Securities Class Action Over Alleged Asset Misstatements

Navan Faces Securities Class Action Over IPO Disclosures as Lead-Plaintiff Push Builds

Lead‑Plaintiff Deadline Hits Today in Bath & Body Works Securities Case

Richtech Robotics Investors Urged to Act as April 3 Lead‑Plaintiff Deadline Nears

Richtech Robotics Faces Wave of Securities Suits Over Microsoft Claims as Lead Plaintiff Deadline Nears

Ramaco Resources Class Action Pushes Toward Lead-Plaintiff Deadline

Ramaco Resources Investors Urged to Seek Lead Role in Securities Suit Before March 31 Deadline

Investors Sought to Lead Masonite Share-Buyback Lawsuit Citing Owens Corning Offers

Varonis Investors Urged to Seek Lead Role in SDNY Securities Suit as March 9 Deadline Nears

Bath & Body Works Investors Courted in Securities Class Action Over Marketing Claims

Gauzy Investors Face Feb. 6 Lead‑Plaintiff Deadline in Securities Class Action

Integer Faces Securities Class Action Over EP Device Claims as Lead Plaintiff Deadline Nears

Sprouts Securities Lawsuits Hit Lead-Plaintiff Deadline

Varonis Investors Face March 9 Deadline to Lead Securities Class Action Over SaaS Conversion Claims

Agilon Health Investors Face March 2 Deadline in Competing Securities Class Actions

Sprouts Investors Face Jan. 26 Deadline to Seek Lead Role in Securities Class Action

SLM Securities Class Action Enters Lead-Plaintiff Phase Ahead of Feb. 17 Deadline

Competing Securities Class Actions Target Agilon Health Over 2025 Guidance